IPC The Hospitalist Company (NASDAQ:IPCM) Roaring on Acquisition Pipeline

IPC The Hospitalist Company (NASDAQ:IPCM) share price has been hot, and Jefferies believes that will continue as acquisitions and organic growth continue to grow the company.

Jefferies stated, "IPCM's acute and post-acute acquisition pipeline is red hot and will likely provide the company with incremental growth opportunities above and beyond what it is capturing today organically."

For full year 2011, EPS estimate was raised from $1.73 to $1.80, while revenue for full year 2010 was raised from $360.7 million to $361.1 million and for 2011 from $417.7 million to $436.3 million.

Jefferies maintains their "Buy" rating on IPC, which closed Thursday at $34.77, rising by $0.65, or 1.91 percent. They raised their price target on them from $39 to $41.